Edwards Lifesciences Corp

EW 10-Q · Q2 2025
API behind this page

EW Q2 2025 request

Playground key active
Request URL /api/financials?ticker=EW&year=2025&quarter=2
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q2 2025 Q2 2024 YoY
Revenue 1,532.2 1,369.4 +11.9%
Show Product Lines breakouts
Surgical Structural Heart 266.8 247.8 +7.7%
Transcatheter Aortic Valve Replacement 1,130.9 1,038.6 +8.9%
Transcatheter Mitral and Tricuspid Therapies 134.5 83 +62.0%
Show Business Segments breakouts
Europe · Operating Segments 378.2 332.2 +13.8%
Japan · Operating Segments 95.3 86.5 +10.2%
Rest of World · Operating Segments 169 144.3 +17.1%
United States · Operating Segments 889.7 806.4 +10.3%
Show Consolidation Items breakouts
Operating Segments 1,532.2 1,369.4 +11.9%
Cost of Revenue 344.4 275.5 +25.0%
Show Business Segments breakouts
Europe · Operating Segments 84.8 74.4 +14.0%
Japan · Operating Segments 13.6 12.6 +7.9%
Rest of World · Operating Segments 43.9 40.3 +8.9%
United States · Operating Segments 167.5 146.4 +14.4%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income -10.9 -12.5 +12.8%
Show Consolidation Items breakouts
Operating Segments 309.8 273.7 +13.2%
Gross Profit 1,187.8 1,093.9 +8.6%
Selling, General & Administrative 502 447.5 +12.2%
Show Business Segments breakouts
Europe · Operating Segments 74.2 70.9 +4.7%
Japan · Operating Segments 18.5 19.6 -5.6%
Rest of World · Operating Segments 48.3 46.6 +3.6%
United States · Operating Segments 135.7 117.8 +15.2%
Show Consolidation Items breakouts
Operating Segments 276.7 254.9 +8.6%
Research & Development 276.2 271.8 +1.6%
Litigation Settlement Expense 15.5 8.1 +91.4%
Show Consolidation Items breakouts
Material Reconciling Items 15.5 8.1 +91.4%
Restructuring Settlement And Impairment Provisions 4.2 — —
Show Consolidation Items breakouts
Material Reconciling Items 4.2 — —
Other Operating Income Expense Net -21.3 — —
Operating Income 411.2 366.5 +12.2%
Show Consolidation Items breakouts
Operating Segments 938 845.9 +10.9%
Interest Income Expense Nonoperating Net -37.4 -15.5 -141.3%
Show Equity Components breakouts
Accumulated Net Unrealized Investment Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income -19 1 -2000.0%
Asset Impairment Charges 47.1 — —
Other Non-Operating Income (Expense) 1.3 -2 +165.0%
Show Equity Components breakouts
Accumulated Translation Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income -1.5 -1.8 +16.7%
Income Before Taxes 400.2 384 +4.2%
Income Tax Expense (Benefit) 64.3 20 +221.5%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income 2.8 3.2 -12.5%
Accumulated Net Unrealized Investment Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income 4.6 -0.3 +1633.3%
Accumulated Translation Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income 0.4 0.4 0.0%
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest 335.9 364 -7.7%
Income Loss From Discontinued Operations Net Of Tax -4.4 1 -540.0%
Net Income 331.5 365 -9.2%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income 8.1 9.3 -12.9%
Accumulated Net Unrealized Investment Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income 14.4 -0.7 +2157.1%
Accumulated Translation Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income 1.1 1.4 -21.4%
Noncontrolling Interest -1.7 -1.3 -30.8%
Parent 333.2 366.3 -9.0%
Retained Earnings 333.2 366.3 -9.0%
Net Income Loss Attributable To Noncontrolling Interest -1.7 -1.3 -30.8%
Net Income 333.2 366.3 -9.0%
Income Loss From Continuing Operations Per Basic Share 0.58 0.61 -4.9%
Income Loss From Discontinued Operations Net Of Tax Per Basic Share -0.01 — —
EPS (Basic) 0.57 0.61 -6.6%
Income Loss From Continuing Operations Per Diluted Share 0.57 0.61 -6.6%
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share -0.01 — —
EPS (Diluted) 0.56 0.61 -8.2%
Wtd Avg Shares (Basic) 587 602.1 -2.5%
Wtd Avg Shares (Diluted) 587.9 604.3 -2.7%
Total Costs & Expenses (Q) — — —
Show Consolidation Items breakouts
Corporate Non Segment -505.2 -480.8 -5.1%
Non-Operating Income (Expense) -11 17.5 -162.9%
Comprehensive Income 323.6 379.4 -14.7%
Other Comprehensive Income -9.6 13.1 -173.3%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -9.6 13.1 -173.3%
Parent -9.6 13.1 -173.3%
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments (Q) — — —
Show Business Segments breakouts
Europe · Operating Segments 204 186.1 +9.6%
Japan · Operating Segments 63.4 57.9 +9.5%
Rest of World · Operating Segments 84.7 60.4 +40.2%
United States · Operating Segments 585.9 541.5 +8.2%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income 10.9 12.5 -12.8%
Show Consolidation Items breakouts
Operating Segments 938 845.9 +10.9%
Interest Income Expense Net 37.4 15.5 +141.3%
Foreign Currency Transaction Gain Loss Before Tax (Q) — — —
Show Consolidation Items breakouts
Material Reconciling Items -1.9 9.5 -120.0%

Balance Sheet

Balance Sheet
Metric Q2 2025 Q2 2024 YoY
Current Assets
Cash & Cash Equivalents 3,272.8 1,644.5 +99.0%
Show Statement Operating Activities Segment breakouts
Segment Continuing Operations 3,272.8 1,644.5 +99.0%
Segment Discontinued Operations 15 9.2 +63.0%
Short-Term Investments 789.4 345.3 +128.6%
Accounts Receivable 697 778.3 -10.4%
Other Receivables Net Current 205.6 56.1 +266.5%
Inventory 1,141.7 1,024.7 +11.4%
Prepaid Expense Current 110 110.2 -0.2%
Other Assets Current 314.4 252.1 +24.7%
Assets Of Disposal Group Including Discontinued Operation Current 46.3 — —
Show Disposal Group Classification breakouts
Discontinued Operations Disposed Of By Sale · Critical Care 46.3 — —
Total Current Assets 6,577.2 4,516 +45.6%
Non-Current Assets
Long Term Investments 298.5 353.3 -15.5%
Property, Plant & Equipment 1,726.6 1,640.1 +5.3%
Operating Lease Right-of-Use Assets 99 92.8 +6.7%
Goodwill 1,776.7 1,151 +54.4%
Deferred Tax Assets 1,082.1 832.6 +30.0%
Other Non-Current Assets 743 789.8 -5.9%
Disposal Group Including Discontinued Operation Assets Noncurrent 12.8 — —
Show Disposal Group Classification breakouts
Discontinued Operations Disposed Of By Sale · Critical Care 12.8 — —
Total Assets 13,488.7 10,099.3 +33.6%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 242.8 262.5 -7.5%
Other Assets
Intangible Assets Net Excluding Goodwill 1,172.8 417.1 +181.2%
Current Liabilities
Accounts Payable 162.1 185.9 -12.8%
Accrued And Other Liabilities Current 1,214.4 902.4 +34.6%
Operating Lease Liability Current 25.9 21.5 +20.5%
Liabilities Of Disposal Group Including Discontinued Operation Current 2.3 — —
Show Disposal Group Classification breakouts
Discontinued Operations Disposed Of By Sale · Critical Care 2.3 — —
Total Current Liabilities 1,404.7 1,217 +15.4%
Non-Current Liabilities
Long-Term Debt 598 597.3 +0.1%
Operating Lease Liabilities 78.7 74.2 +6.1%
Liability For Uncertain Tax Positions Noncurrent 421.6 343.2 +22.8%
Other Non-Current Liabilities 379.2 257.1 +47.5%
Total Liabilities 2,882.2 2,594.7 +11.1%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 23.3 27.2 -14.3%
Stockholders' Equity
Common Stock 657.6 653.5 +0.6%
Additional Paid In Capital Common Stock 2,750 2,476.3 +11.1%
Retained Earnings 13,858.2 9,710.6 +42.7%
Accumulated Other Comprehensive Income -264.1 -220.2 -19.9%
Treasury Stock Common Value -6,456.4 -5,182.8 -24.6%
Total Stockholders' Equity 10,545.3 — —
Minority Interest 61.2 67.2 -8.9%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 10,606.5 7,504.6 +41.3%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -4.1 -4 -2.5%
Accumulated Gain Loss Net Cash Flow Hedge Parent -43.8 34.5 -227.0%
Accumulated Net Unrealized Investment Gain Loss -2.1 -11.1 +81.1%
Accumulated Other Comprehensive Income -264.1 -220.2 -19.9%
Accumulated Translation Adjustment -214.1 -239.6 +10.6%
Additional Paid In Capital 2,750 2,476.3 +11.1%
Common Stock 657.6 653.5 +0.6%
Noncontrolling Interest 61.2 67.2 -8.9%
Parent 10,545.3 7,437.4 +41.8%
Retained Earnings 13,858.2 9,710.6 +42.7%
Treasury Stock Common -6,456.4 -5,182.8 -24.6%
Total Liabilities & Equity 13,488.7 10,099.3 +33.6%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q2 2025 YTD Q2 2024 YoY
Operating Activities
Depreciation & Amortization 74.7 78.1 -4.4%
Operating Lease Right Of Use Asset Amortization Expense 12.5 15.1 -17.2%
Stock-Based Compensation 77.7 88.5 -12.2%
Increase Decrease In Deferred Income Taxes -45.2 -101.9 +55.6%
Other Non-Cash Items 8.3 2 +315.0%
Increase Decrease In Accounts And Other Receivables -68.6 -32 -114.4%
Change in Inventory 41.5 -163.7 +125.4%
Increase Decrease In Accounts Payable And Accrued Liabilities 0.3 62.7 -99.5%
Increase Decrease In Accrued Income Taxes Payable -189.2 -370 +48.9%
Change in Prepaid & Other Assets -3.3 40.1 -108.2%
Increase Decrease In Legal Settlement Accrual -49.2 -11.8 -316.9%
Increase Decrease In Other Operating Capital Net -23.9 -5.1 -368.6%
Net Cash from Operations 570.6 318 +79.4%
Investing Activities
Capital Expenditures -105.3 -150.7 +30.1%
Payments To Acquire Interest In Subsidiaries And Affiliates -48.3 -6 -705.0%
Payments To Acquire Held To Maturity Securities -18.8 -14.1 -33.3%
Proceeds From Sale And Maturity Of Held To Maturity Securities 32 25.2 +27.0%
Purchases of Investments -1,258.8 -1.8 -69833.3%
Proceeds From Sale And Maturity Of Available For Sale Securities 1,439.7 388.4 +270.7%
Disposal Group Payment For Working Capital Adjustment -36.3 — —
Show Counterparty Name breakouts
Becton, Dickinson and Company · Critical Care -36.3 — —
Other Payments To Acquire Businesses -17 -10.8 -57.4%
Payments To Acquire Receivables -70.6 -17.5 -303.4%
Other Investing Activities -3.4 -4.8 +29.2%
Net Cash from Investing -86.8 187.9 -146.2%
Financing Activities
Share Repurchases -264.1 -158.3 -66.8%
Payments For Equity Forward Contract Related To Accelerated Share Repurchase Agreement -50 — —
Proceeds From Stock Plans 107.1 116.4 -8.0%
Proceeds From Payments For Other Financing Activities 1.7 7 -75.7%
Net Cash from Financing -205.3 -34.9 -488.3%
Supplemental
Unpaid Capital Expenditures 31.9 24.1 +32.4%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -47.3 39.1 -221.0%
Net Change in Cash 231.2 510.1 -54.7%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3,290 1,658.1 +98.4%
Show Statement Operating Activities Segment breakouts
Segment Continuing Operations 3,275 1,648.9 +98.6%
Segment Discontinued Operations 15 9.2 +63.0%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key